- Home
- AQST vs GAU Comparison
AQST vs GAU Comparison
Compare AQST & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQST | GAU |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 606.0M |
| IPO Year | 2007 | 2006 |
Fundamental Metrics
Financial Performance| Metric | AQST | GAU |
|---|---|---|
| Price | $4.68 | $2.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $9.00 | $4.08 |
| AVG Volume (30 Days) | ★ 3.6M | 3.0M |
| Earning Date | 05-01-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $10.08 | $82.77 |
| Revenue Next Year | $49.60 | $29.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.94 | $1.66 |
| 52 Week High | $7.55 | $3.62 |
Technical Indicators
Market Signals| Indicator | AQST | GAU |
|---|---|---|
| Relative Strength Index (RSI) | 66.99 | 69.94 |
| Support Level | $4.03 | $2.14 |
| Resistance Level | $5.10 | $2.37 |
| Average True Range (ATR) | 0.25 | 0.09 |
| MACD | 0.08 | 0.04 |
| Stochastic Oscillator | 94.98 | 93.16 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.